Cargando…

microRNA-21 Regulates Stemness in Pancreatic Ductal Adenocarcinoma Cells

Pancreatic ductal adenocarcinoma (PDAC) is the most common and aggressive type of pancreatic cancer (PCa) with a low survival rate. microRNAs (miRs) are endogenous, non-coding RNAs that moderate numerous biological processes. miRs have been associated with the chemoresistance and metastasis of PDAC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mortoglou, Maria, Miralles, Francesc, Arisan, Elif Damla, Dart, Alwyn, Jurcevic, Stipo, Lange, Sigrun, Uysal-Onganer, Pinar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8835847/ https://www.ncbi.nlm.nih.gov/pubmed/35163198 http://dx.doi.org/10.3390/ijms23031275

Ejemplares similares

Non-coding RNAs in pancreatic ductal adenocarcinoma: New approaches for better diagnosis and therapy
por: Mortoglou, Maria, et al.
Publicado: (2021)

The Prediction of miRNAs in SARS-CoV-2 Genomes: hsa-miR Databases Identify 7 Key miRs Linked to Host Responses and Virus Pathogenicity-Related KEGG Pathways Significant for Comorbidities
por: Arisan, Elif Damla, et al.
Publicado: (2020)

MiR-21 Is Required for the Epithelial–Mesenchymal Transition in MDA-MB-231 Breast Cancer Cells
por: Arisan, Elif Damla, et al.
Publicado: (2021)

Putative Roles for Peptidylarginine Deiminases in COVID-19
por: Arisan, Elif Damla, et al.
Publicado: (2020)

MicroRNAs for Virus Pathogenicity and Host Responses, Identified in SARS-CoV-2 Genomes, May Play Roles in Viral-Host Co-Evolution in Putative Zoonotic Host Species
por: Lange, Sigrun, et al.
Publicado: (2021)

Role of microRNAs in response to cadmium chloride in pancreatic ductal adenocarcinoma
por: Mortoglou, Maria, et al.
Publicado: (2021)

Wnt-11 Expression Promotes Invasiveness and Correlates with Survival in Human Pancreatic Ductal Adeno Carcinoma
por: Dart, Dafydd A., et al.
Publicado: (2019)

Nickel’s Role in Pancreatic Ductal Adenocarcinoma: Potential Involvement of microRNAs
por: Mortoglou, Maria, et al.
Publicado: (2022)

microRNA 1307 Is a Potential Target for SARS-CoV-2 Infection: An in Vitro Model
por: Arisan, Elif Damla, et al.
Publicado: (2022)

Peptidylarginine Deiminase Inhibitor Application, Using Cl-Amidine, PAD2, PAD3 and PAD4 Isozyme-Specific Inhibitors in Pancreatic Cancer Cells, Reveals Roles for PAD2 and PAD3 in Cancer Invasion and Modulation of Extracellular Vesicle Signatures
por: Uysal-Onganer, Pinar, et al.
Publicado: (2021)

Prostate-specific PTen deletion in mice activates inflammatory microRNA expression pathways in the epithelium early in hyperplasia development
por: Dart, D. Alwyn, et al.
Publicado: (2017)

The Role of CDK4 in the Pathogenesis of Pancreatic Cancer
por: Jiggens, Emily, et al.
Publicado: (2021)

Inhibition on JNK Mimics Silencing of Wnt-11 Mediated Cellular Response in Androgen-Independent Prostate Cancer Cells
por: Arisan, Elif Damla, et al.
Publicado: (2020)

Upregulated Wnt-11 and miR-21 Expression Trigger Epithelial Mesenchymal Transition in Aggressive Prostate Cancer Cells
por: Arisan, Elif Damla, et al.
Publicado: (2020)

Specific c-Jun N-Terminal Kinase Inhibitor, JNK-IN-8 Suppresses Mesenchymal Profile of PTX-Resistant MCF-7 Cells through Modulating PI3K/Akt, MAPK and Wnt Signaling Pathways
por: Ozfiliz Kilbas, Pelin, et al.
Publicado: (2020)

In Vitro Investigations of miR-33a Expression in Estrogen Receptor-Targeting Therapies in Breast Cancer Cells
por: Ozfiliz-Kilbas, Pelin, et al.
Publicado: (2021)

Prohibitin Links Cell Cycle, Motility and Invasion in Prostate Cancer Cells
por: Koushyar, Sarah, et al.
Publicado: (2023)

Splice variants as novel targets in pancreatic ductal adenocarcinoma
por: Wang, Jun, et al.
Publicado: (2017)

Prostate Cancer Cell Extracellular Vesicles Increase Mineralisation of Bone Osteoblast Precursor Cells in an In Vitro Model
por: Lanning, Ben, et al.
Publicado: (2021)

Protein Deimination Signatures in Plasma and Plasma-EVs and Protein Deimination in the Brain Vasculature in a Rat Model of Pre-Motor Parkinson’s Disease
por: Sancandi, Marco, et al.
Publicado: (2020)

Prognostic value of microRNA-21 in pancreatic ductal adenocarcinoma: a meta-analysis
por: Hu, Geng-yuan, et al.
Publicado: (2016)

MicroRNA-21 in Pancreatic Ductal Adenocarcinoma Tumor-Associated Fibroblasts Promotes Metastasis
por: Kadera, Brian E., et al.
Publicado: (2013)

miR-34a-FOXP1 Loop in Ovarian Cancer
por: Dirimtekin, Esra, et al.
Publicado: (2023)

Post-Translational Deimination of Immunological and Metabolic Protein Markers in Plasma and Extracellular Vesicles of Naked Mole-Rat (Heterocephalus glaber)
por: Pamenter, Matthew E., et al.
Publicado: (2019)

Extracellular Vesicles Inhibit the Response of Pancreatic Ductal Adenocarcinoma Cells to Gemcitabine and TRAIL Treatment
por: Rimmer, Ella, et al.
Publicado: (2022)

Nutraceuticals as Supportive Therapeutic Agents in Diabetes and Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Mikolaskova, Iveta, et al.
Publicado: (2023)

Peptidylarginine Deiminases Post-Translationally Deiminate Prohibitin and Modulate Extracellular Vesicle Release and MicroRNAs in Glioblastoma Multiforme
por: Kosgodage, Uchini S., et al.
Publicado: (2018)

The comparison of differentially expressed microRNAs in Bag-1 deficient and wild type MCF-7 breast cancer cells by small RNA sequencing
por: ÖZFİLİZ KILBAŞ, Pelin, et al.
Publicado: (2021)

MicroRNA-100 and microRNA-21 as markers of survival and chemotherapy response in pancreatic ductal adenocarcinoma UICC stage II
por: Dhayat, Sameer Abdallah, et al.
Publicado: (2015)

The State of the Art on Blood MicroRNAs in Pancreatic Ductal Adenocarcinoma
por: Gao, Zhuqing, et al.
Publicado: (2019)

Significance of High-Mobility Group A Protein 2 Expression in Pancreatic Ductal Adenocarcinoma and Ampullary Adenocarcinoma
por: Oflas, Damla, et al.
Publicado: (2023)

Palbociclib suppresses the cancer stem cell properties and cell proliferation through increased levels of miR-506 or miR-150 in Panc-1 and MiaPaCa-2 cells
por: RENCÜZOĞULLARI, Özge, et al.
Publicado: (2022)

microRNA expression in acute myeloid leukaemia: New targets for therapy?
por: Fletcher, Daniel, et al.
Publicado: (2022)

Peptidylarginine Deiminase Isozyme-Specific PAD2, PAD3 and PAD4 Inhibitors Differentially Modulate Extracellular Vesicle Signatures and Cell Invasion in Two Glioblastoma Multiforme Cell Lines
por: Uysal-Onganer, Pinar, et al.
Publicado: (2020)

Synthesis and characterization of novel ssDNA X-aptamers targeting Growth Hormone Releasing Hormone (GHRH)
por: Ayhan-Sahin, Burcu, et al.
Publicado: (2022)

Molecular Analysis of Precursor Lesions in Familial Pancreatic Cancer
por: Crnogorac-Jurcevic, Tatjana, et al.
Publicado: (2013)

A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinoma
por: Haider, Syed, et al.
Publicado: (2014)

MicroRNAs as Indicators of Malignancy in Pancreatic Ductal Adenocarcinoma (PDAC) and Cystic Pancreatic Lesions
por: Prinz, Christian, et al.
Publicado: (2022)

Mimics of pancreatic ductal adenocarcinoma
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Pancreatic ductal adenocarcinoma staging
por: Al-Hawary, Mahmoud M., et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_sa7sfag2av4ks1cs3tq81lltpo